MY ACCOUNT | NEWSLETTER |

Electrochemotherapy association with surgery, overall survival in canine squamous cell carcinoma

Significant correlation found between fur coat color, tumor development in areas of sun exposure


Squamous cell carcinoma (SCC) is an important malignancy in dogs, due to its incidence and clinical presentation, which can be of locally aggressive single or multiple lesions with a metastatic potential. The objective of this investigation was to evaluate SCC response to treatment, anatomopathological and immunohistochemical characteristics, disease-free interval and overall survival time. 

Researchers included 54 dogs with histopathologically diagnosed SCC in this study. Their mean age was 9.16 years with a range of one to 14 years. Of the 54 animals in the study, 34 or 65.4% had white skin and white fur coats. 

There was a significant correlation between fur coat color and the development of tumors in areas of sun exposure (p = 0.001). Animals with tumors in areas of the body exposed to the sun had longer overall survival time than animals with tumors in areas not associated with sun exposure (p = 0.001). 

Surgery combined with electrochemotherapy (ECT) yielded a survival rate 32% higher than using a surgical approach alone (HR = 0.32, p = 0.038, IC = 0.11-0.94). ECT, with or without surgery, had an objective response rate of 90.9%. Local lymph node and/or distant site metastasis at diagnosis, or at some point during follow-up, occurred in 34.6% (18/52) of animals. 

Animals with tumors in sun exposed locations had more aggressive histopathological characteristics but had longer overall survival time. This is probably due to individualized therapeutic treatment with both surgery and ECT.

Rúbia Monteiro de Castro Cunha, et al. “Canine squamous cell carcinoma: electrochemotherapy association with surgery and correlation with overall survival.” Vet Comp Oncol. 6 February 2023.  doi: 10.1111/vco.12882.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

EXPRESS: Azotaemia and outcomes in male cats with initial and recurrent urethral obstruction: a multicentre retrospective study of 601 cats (2020-2024).

Like0
Dislike0

Clinical findings and risk factors for clinical outcomes in dogs with myxomatous mitral valve disease hospitalized for cardiogenic pulmonary edema.

Like0
Dislike0

Soluble triggering receptor expressed on myeloid cells-1 as a predictive biomarker in sepsis: insights into cut-offs, mortality risk, and treatment guidance-secondary analysis of the Next GeneSiS-Trial.

Like0
Dislike0

Texas A&M Research Reveals More Than 84% Of Dogs Show Signs Of Fear, Anxiety

Like0
Dislike0

Veterinary Pharmaceuticals Market Research and Global Forecast Report 2026-2031: Rising Demand for Parasiticides and Dermatology Products and Growth Potential in

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top